Long Professor News Today

Commencement Ceremony for the MD Class of 2024.

Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease, can lead to kidney enlargement and eventual loss of function.

According to the Centers for Disease Control and Prevention, cancer is a leading cause of death in the United States. Unfortunately for American men, prostate

A compound originally developed as a cancer treatment may hold promise for treating polycystic kidney disease (ADPKD), which affects more than half a million Americans and can lead to kidney enlargement and loss of function.

ADPKD, the prevalent form of polycystic kidney disease, causes kidney enlargement, often leading to function loss.

ADPKD, the prevalent form of polycystic kidney disease, causes kidney enlargement, often leading to function loss.

Mitochondria and intermediary metabolism are central to health and disease, yet many of us learn a simplified version of this complex science. To develop

In this episode, hosts discuss data from the PROTECT trial, which examined the effects of teplizumab on beta-cell function in patients with newly diagnosed type 1 diabetes.

The preservation of insulin-producing beta cells is just one of the benefits of teplizumab, also known as Tzield, a phase 3 trial shows.

TZIELD® Phase 3 data presented at ISPAD shows potential to slow the progression of Stage 3 type 1 diabetes in newly diagnosed children and adolescents; full data simultaneously published in The New England